🔎 Trials Near Me

Beranda › Hipertensi Paru › Pennsylvania

Uji klinis Hipertensi Paru di Pennsylvania

13 studi untuk Hipertensi Paru mencari peserta di lokasi di Pennsylvania.

Kota di Pennsylvania

Teks studi resmi (Bahasa Inggris)

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA013, Philadelphia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07179380

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Thomas Jefferson University, Philadelphia
  • Temple University of The Commonwealth System of Higher Education, Philadelphia
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06911632

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

  • University of Pennsylvania Hospital, Philadelphia
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07132788

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • St. Luke's University Health Network, Bethlehem
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
  • dan 2 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06388421

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Menerima pesertaFase 2
Usia 8 hingga 60 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT03630211

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Temple University, Philadelphia
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Abington Memorial Hospital, Abington
  • Penn State Milton S. Hershey Medical Center, Hershey
  • University of Pennsylvania, Philadelphia
  • dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195

iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH

  • Children's Hospital of Philadelphia, Philadelphia
Menerima peserta
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT05442671

Feasibility of Semaglutide in Advanced Lung Disease

  • University of Pennsylvania Perelman School of Medicine, Philadelphia
Menerima pesertaFase 1/2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT05746039

PET Image in PAH Patients

  • Montefiore Hospital Clinical and Translational Research Center, Pittsburgh
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT05452889

Pulmonary Hypertension Association Registry

  • University of Pennsylvania, Philadelphia
  • Allegheny General Hospital, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
Menerima pesertaStudi observasional
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT04071327

Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

  • Temple University Hospital, Philadelphia
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2025 · NCT07151768

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.